b-rayZ
b-rayZ AG is a Zurich-based med-tech company that develops an AI-powered software suite for standardizing breast imaging workflows. It serves hospitals, radiology networks, and screening programs across Europe through enterprise subscriptions and channel partnerships.
- Company typePrivate
- Founded2019
- HeadquartersZürich, Switzerland
- Headcount11–50
- GTM typeB2B
- OfferingSoftware
What b-rayZ does
b-rayZ AG is a Swiss med-tech company headquartered in Zurich and spun out of the University Hospital Zurich. It develops an AI-based software platform, the b-rayZ Suite, that standardizes, streamlines, and digitalizes breast imaging workflows across mammography (FFDM) and digital breast tomosynthesis (DBT) systems. The platform integrates with existing PACS environments and delivers automated BI-RADS ACR classification, image quality assessment, and AI-based decision support to assist radiologists and technicians in early breast cancer detection.
The product is structured as a modular suite addressing three user groups: b-rayZ for Patients, b-rayZ for Institutes and Screening Programs, and b-rayZ for Health Care Professionals, with an additional b-box intelligent mammography module for automated quality checks. The company holds CE marking, ISO 13485 certification, and Swiss Made Software designation, positioning it for sale as a regulated medical device in Europe while it pursues FDA clearance for the United States.
Commercially, b-rayZ sells through enterprise field sales, quote-based multi-year subscriptions, and channel partnerships. Named commercial relationships include a preferred AI partnership with Affidea Group across its European imaging centers (June 2025), a distribution partnership with SC PACS Bulgaria for Eastern Europe (July 2025), and an integration with Biotronics3D unveiled at RSNA 2025. The company is led by co-founder and CEO Prof. Dr. Cristina Rossi and appointed Andrew C. Weiss as CFO in May 2026.
b-rayZ firmographics
Firmographics- Name
- b-rayZ
- Legal name
- b-rayZ AG
- Website
- https://b-rayz.ch
- Company type
- Private
- Founded year
- 2019
- Operating status
- Operating
- Headcount range
- 11–50 employees
- Short description
- b-rayZ AG is a Zurich-based med-tech company that develops an AI-powered software suite for standardizing breast imaging workflows. It serves hospitals, radiology networks, and screening programs across Europe through enterprise subscriptions and channel partnerships.
- Ownership category
- akta.pro rank
b-rayZ industry classification
Industry- Product category
- AI Breast Imaging Software
- NAICS
- Software Publishers (5132)
- SIC
- Services-Computer Programming Services (7371)
- akta.pro primary industry
- AI Orchestration & Imaging Analytics Platforms (Model Management/Triage) (HLACALAG)
- akta.pro secondary industries
- Mammography & Breast Imaging Systems (HLAHABAF), Radiology Reporting, Dictation & Structured Reporting (HLACALAF), Imaging & Diagnostic Interoperability (DICOM exchange, image sharing, VNA connectivity) (HLACABAM), Women’s Imaging & Breast Health Centers (HLAFAJAJ)
Keywords
Where b-rayZ is headquartered
LocationHeadquarters
- HQ city
- Zürich
- HQ country
- Switzerland
- HQ region
- Europe
Offices1 record
Markets served
b-rayZ business model
Business model- GTM type
- B2B
- Offering type
- Software
- Cost components
- Personnel, Technology or R&D, Marketing or Sales, Operations
Revenue model
- AI Breast Imaging Platform Subscriptions: b-rayZ operates as a B2B healthcare software provider offering AI-powered breast imaging solutions to healthcare institutions. The modular platform approach suggests a recurring subscription model where healthcare facilities pay for access to the b-rayz suite modules. The company provides solutions for different customer segments (Patients, Institutes, Health Care Professionals), indicating potential for tiered pricing based on facility size and module usage.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Subscription | Multi-year contract | Enterprise subscription model - custom pricing |
Go-to-market motion2 records
Distribution channels3 records
Marketing channels4 records
b-rayZ product offering
Product offeringCore offering
b-rayZ develops and sells an AI-powered modular software platform (b-rayZ Suite) for breast imaging that supports radiologists, technicians, and clinical managers with automated image analysis, BI-RADS ACR and Image Quality classification, and AI-based decision support. The platform integrates with full-field digital mammography, digital breast tomosynthesis, and PACS environments to standardize, streamline, and digitalize breast imaging workflows for hospitals, radiology networks, and breast screening programs.
Product overview
b-rayZ offers a modular end-to-end platform for breast imaging called the b-rayZ Suite. The platform provides AI-powered solutions designed to integrate with full-field digital mammography and digital breast tomosynthesis systems as well as existing PACS environments. The suite includes specialized modules for different users: b-rayZ for Patients (providing accurate and standardized evaluation), b-rayZ for Institutes & Screening Programs (supporting clinical managers and IT personnel), and b-rayZ for Health Care Professionals (offering intelligent tools for radiologists and technicians). Key AI capabilities include automatic BI-RADS ACR classification and Image Quality assessments, with the b-box module specifically mentioned as an intelligent mammography tool that automates quality checks. The platform is CE-marked and operates with Swiss precision, supporting standardized breast imaging workflows across Europe.
Differentiator
Problem solved
Functional benefit
Products and services
- b-rayZ Suite Ever-expanding, modular end-to-end AI platform for breast imaging that delivers AI-supported results within the clinical workflow with automatic BI-RADS ACR and Image Quality classifications. Designed for radiologists, technicians, clinical managers, and IT personnel supporting breast imaging units, integrating with FFDM, DBT, and PACS systems.
- b-rayZ for Health Care Professionals Solution offering intelligent tools for radiologists and technicians providing patient care, including AI-based decision support and automated quality checks integrated into the clinical workflow for breast imaging diagnostics.
- b-rayZ for Institutes & Screening Programs Solution for clinical managers and IT personnel supporting breast imaging units at institutes, hospitals, and screening programs, elevating workflow through standardized procedures, centralized management, and quality assurance tools.
- b-rayZ for Patients Patient-facing solution providing accurate and standardized evaluation to support the patient journey through breast imaging diagnostics, offering AI-assisted diagnostic accuracy and consistency for women undergoing breast cancer screening.
- b-box Intelligent mammography tool that automates quality checks and supports visual inspection, designed to provide excellent care to every patient through automated quality assurance within the breast imaging workflow.
Quantifiable outcome
- Early breast cancer diagnostics saves lives
Companies that use b-rayZ
Customer profileNamed customers2 records
Segments3 records
Ideal customer profiles2 records
b-rayZ technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Integration4 records
AI capability4 records
Feature4 records
b-rayZ partnerships and signals
Strategic signalPartnerships
Three partnerships are on record, tiered flagship and core.
- Biotronics3DflagshipBiotronics3D collaborated with b-rayZ and Affidea to unveil a breakthrough AI-integrated breast imaging workflow at RSNA 2025. This partnership integrates b-rayZ's AI technology with Biotronics3D's imaging platform to create a comprehensive AI-powered breast imaging solution.
- SC PACS Bulgariacoreb-rayZ entered a strategic partnership with SC PACS Bulgaria to advance AI-powered breast imaging across Eastern Europe. SC PACS Bulgaria, as a regional healthcare IT provider, will distribute and implement b-rayZ's AI solutions in their markets, expanding b-rayZ's geographic reach.
- Affidea GroupcoreAffidea Group, a leading European healthcare provider, selected b-rayZ as its preferred AI partner in breast imaging. This strategic collaboration marks a significant partnership where Affidea will integrate b-rayZ's AI solutions across their imaging centers in Europe, providing standardized AI-powered breast imaging workflow capabilities.
Scale indicators2 records
Recent moves7 records
Expansion highlights6 records
b-rayZ competitors and assessment
Company assessmentDirect peers
- Volpara Health Technologies: Volpara offers an AI-driven breast imaging platform covering mammography quality, density assessment, and reporting. It competes directly with b-rayZ's breast imaging workflow, BI-RADS classification, and image quality positioning, and is similarly sold into screening programs and enterprise imaging networks.
- ScreenPoint Medical: ScreenPoint Medical develops Transpara, an AI decision-support tool for breast imaging reading on mammography and tomosynthesis. It overlaps directly with b-rayZ's AI-based decision support and BI-RADS ACR classification capabilities and is sold to the same radiology customer base.
- iCAD: iCAD provides ProFound AI for digital breast tomosynthesis and mammography, a direct competitor in AI-based breast cancer detection and risk scoring. It addresses the same radiologist and breast center customer segments that b-rayZ targets.
- Lunit: Lunit's INSIGHT MMG provides AI breast cancer detection on mammography and is sold globally to screening programs and imaging centers. It is a direct competitor in AI breast imaging with broader geographic reach and a publicly listed balance sheet versus b-rayZ's private Series A stage.
- Therapixel: Therapixel's MammoScreen is an AI-based mammography decision support tool for radiologists, directly comparable to b-rayZ's AI decision support and clinical workflow focus in breast imaging.
Emerging players
- Densitas: Densitas provides AI-driven breast density and image quality analytics on mammograms, partially overlapping b-rayZ's image quality and BI-RADS classification focus. It is a smaller, focused competitor in breast AI quality management.
Broad incumbents
- Hologic: Hologic is a dominant mammography and breast biopsy hardware vendor and increasingly bundles AI features into its 3Dimensions and Genius systems. As the dominant modality vendor, it can integrate competing breast AI features and constrain standalone vendors like b-rayZ at the console level.
- GE HealthCare: GE HealthCare sells leading mammography and tomosynthesis systems and partners with or develops breast AI applications (e.g., via its Edison platform). As a broad incumbent, it competes indirectly by owning the imaging hardware stack that b-rayZ integrates with.
- Siemens Healthineers: Siemens Healthineers produces mammography systems (e.g., Mammomat) and integrates AI-driven breast imaging features through its digital health platform. It competes indirectly as the underlying modality vendor to b-rayZ's target hospital customers.
- Fujifilm Healthcare: Fujifilm provides digital mammography and breast imaging solutions across Europe and globally and increasingly offers AI-assisted tools. As a broad imaging incumbent, it competes indirectly for the same hospital and screening-program budgets that b-rayZ targets.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat5 records
Key risks6 records
Key highlights6 records
Customer concentration
b-rayZ social profiles
Digital presenceb-rayZ compliance and trust
Trust signalCompliance3 records
b-rayZ financial estimates
Financial estimateRevenue estimate
Valuation estimate
b-rayZ leadership team
Management profileNumber of profiles
Profiles4 records
b-rayZ funding detail
Funding detailFunding overview
Funding rounds4 records
Investors8 records
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
b-rayZ M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about b-rayZ
What does b-rayZ do?
b-rayZ develops and sells an AI-powered modular software platform (b-rayZ Suite) for breast imaging that supports radiologists, technicians, and clinical managers with automated image analysis, BI-RADS ACR and Image Quality classification, and AI-based decision support. The platform integrates with full-field digital mammography, digital breast tomosynthesis, and PACS environments to standardize, streamline, and digitalize breast imaging workflows for hospitals, radiology networks, and breast screening programs.
Is b-rayZ a public or private company?
b-rayZ is a private company. It is classified as venture growth investor backed and is currently operating.
When was b-rayZ founded?
b-rayZ was founded in 2019. It employs 11 to 50 people.
Where is b-rayZ based?
b-rayZ is headquartered in Zürich, Switzerland, in the Europe region.
How does b-rayZ make money?
One revenue line is on record: AI Breast Imaging Platform Subscriptions.
Who are b-rayZ's main competitors?
Direct peers on record are Volpara Health Technologies, ScreenPoint Medical, iCAD, Lunit and Therapixel. Densitas is listed as an emerging player. Broad incumbents are Hologic, GE HealthCare, Siemens Healthineers and Fujifilm Healthcare.
Does b-rayZ have an API?
No public API is recorded for b-rayZ.
What industry is b-rayZ in?
b-rayZ's product category is AI Breast Imaging Software. Its primary akta.pro industry code is HLACALAG, AI Orchestration & Imaging Analytics Platforms (Model Management/Triage), with a secondary code of HLAHABAF, Mammography & Breast Imaging Systems. Its NAICS code is 5132 and its SIC code is 7371.